newsfilter
← Latest News
Business Wire·

Savara Announces Proposed Public Offering

Savara Inc. (NASDAQ:SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an underwritten public offering of shares of its common